https://clinicaltrials.gov/ct2/show/NCT02677688?type=Intr&cond=Lupus&phase=012345&lupd_s=02%2F26%2F2019&lupd_d=14
Condition : Serologically Active Adult Systemic Lupus Erythematosus
Intervention : Biological: Autologous EBV specific CTL infusion
Sponsor : Nantes University Hospital
Recruiting
Autologous EBV-specific Cytotoxic T Cells for the Treatment of Systemic Lupus Erythematosus (SLE)
NCT02677688
Tue, 09 Feb 2016 12:00:00 EST
